Q1 2025 Holdings
Filed 2025-05-15 | 54 holdings | $335.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Icon PLC(ICLR) | SHS | G4705A100 | $35.6M | 203,311 | 10.6% |
| Maximus Inc(MMS) | COM | 577933104 | $31.9M | 468,352 | 9.5% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $24.3M | 270,596 | 7.2% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $21.2M | 187,685 | 6.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.7M | 187,573 | 6.2% |
| Labcorp Holdings Inc(LH) | COM SHS | 504922105 | $19.5M | 83,873 | 5.8% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $18.3M | 507,562 | 5.5% |
| Globus MED Inc(GMED) | CL A | 379577208 | $15.2M | 207,000 | 4.5% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $14.9M | 107,780 | 4.4% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $14.1M | 1,107,613 | 4.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $10.0M | 141,134 | 3.0% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $8.6M | 2,369,960 | 2.6% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $8.5M | 133,966 | 2.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $6.6M | 3,397,786 | 2.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $6.5M | 1,514,300 | 1.9% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $5.8M | 87,298 | 1.7% |
| Soleno Therapeutics Inc(SLNO)Put | COM | 834203309 | $5.6M | 78,300 | 1.7% |
| Septerna Inc(SEPN) | COM | 81734D104 | $4.6M | 788,670 | 1.4% |
| Praxis Precision Medicines Inc I(PRAX) | COM NEW | 74006W207 | $4.3M | 112,500 | 1.3% |
| Avanos MED Inc(AVNS) | COM | 05350V106 | $4.1M | 285,989 | 1.2% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $4.1M | 3,735,396 | 1.2% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $3.9M | 416,617 | 1.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $3.6M | 73,511 | 1.1% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $3.6M | 500,000 | 1.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $3.4M | 85,000 | 1.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $3.1M | 473,607 | 0.9% |
| Artivion Inc(AORT) | COM | 228903100 | $3.0M | 121,178 | 0.9% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $3.0M | 2,582,655 | 0.9% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $2.7M | 2,054,593 | 0.8% |
| Vaxart Inc(VXRT) | COM NEW | 92243A200 | $2.3M | 5,583,448 | 0.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.2M | 121,000 | 0.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $2.1M | 116,997 | 0.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.0M | 123,000 | 0.6% |
| Savara Inc(SVRA) | COM | 805111101 | $2.0M | 719,654 | 0.6% |
| Erasca Inc(ERAS) | COM | 29479A108 | $1.9M | 1,356,186 | 0.6% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $1.7M | 315,105 | 0.5% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $1.5M | 1,017,616 | 0.4% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $1.5M | 180,720 | 0.4% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $1.1M | 391,629 | 0.3% |
| Alector Inc(ALEC) | COM | 014442107 | $1.0M | 837,159 | 0.3% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $977.1K | 177,004 | 0.3% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $813.0K | 1,328,352 | 0.2% |
| Tela BIO Inc(TELA) | COM | 872381108 | $768.6K | 630,000 | 0.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $696.2K | 2,232,000 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $572.4K | 71,458 | 0.2% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $564.3K | 276,603 | 0.2% |
| Foghorn Therapeutics Inc.(FHTX) | COM | 344174107 | $444.1K | 121,672 | 0.1% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $354.9K | 50,839 | 0.1% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $274.7K | 251,990 | 0.1% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $244.7K | 162,058 | 0.1% |